Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Neumora Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +38 vs. Q2 2023
- Shares held
- 36.4M
- +36.4M vs. Q2 2023
- Total value
- $512.0M
- +$512.0M vs. Q2 2023
- New holders
- 38
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $129.2M |
| Q1 2026 | 114 | $137.2M |
| Q4 2025 | 102 | $112.7M |
| Q3 2025 | 93 | $92.2M |
| Q2 2025 | 98 | $41.1M |
| Q1 2025 | 116 | $65.2M |
| Q4 2024 | 135 | $851.6M |
| Q3 2024 | 104 | $907.0M |
| Q2 2024 | 93 | $627.4M |
| Q1 2024 | 88 | $725.4M |
| Q4 2023 | 60 | $744.8M |
| Q3 2023 | 38 | $512.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Neumora Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Salem Investment Counselors Inc | 100 | $1.41K | 0.00% | +100 | New |
| Morgan Stanley | 400 | $5.64K | 0.00% | +400 | New |
| Legal & General Group Plc | 10,000 | $140.3K | 0.00% | +10,000 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 10,000 | $141.1K | 0.00% | +10,000 | New |
| Ghisallo Capital Management LLC | 10,000 | $141.1K | 0.01% | +10,000 | New |
| Zimmer Partners, LP | 12,500 | $176.4K | 0.00% | +12,500 | New |
| Citigroup Inc | 14,416 | $203.4K | 0.00% | +14,416 | New |
| Royal Bank of Canada | 20,078 | $283.0K | 0.00% | +20,078 | New |
| Qube Research & Technologies Ltd | 21,400 | $302.0K | 0.00% | +21,400 | New |
| Laurion Capital Management LP | 21,557 | $304.2K | 0.01% | +21,557 | New |
| BlackRock Inc. | 25,000 | $352.7K | 0.00% | +25,000 | New |
| First Trust Advisors LP | 26,770 | $377.7K | 0.00% | +26,770 | New |
| Susquehanna International Group, LLP | 28,834 | $406.8K | 0.00% | +28,834 | New |
| Point72 Middle East FZE | 43,713 | $616.8K | 0.04% | +43,713 | New |
| Greenland Capital Management LP | 47,613 | $671.8K | 0.08% | +47,613 | New |
| Vanguard Group Inc | 50,000 | $705.5K | 0.00% | +50,000 | New |
| Norges Bank | 50,000 | $705.5K | 0.00% | +50,000 | New |
| Two Sigma Investments, LP | 58,500 | $825.4K | 0.00% | +58,500 | New |
| Goldman Sachs Group Inc | 73,600 | $1.04M | 0.00% | +73,600 | New |
| Cormorant Asset Management, LP | 92,293 | $1.30M | 0.08% | +92,293 | New |
| Geode Capital Management, LLC | 122,186 | $1.72M | 0.00% | +122,186 | New |
| Scoggin Management LP | 150,000 | $2.12M | 2.86% | +150,000 | New |
| Ensign Peak Advisors, Inc | 150,000 | $2.12M | 0.00% | +150,000 | New |
| Alphabet Inc. | 199,608 | $2.82M | 0.18% | +199,608 | New |
| Marshall Wace, LLP | 256,412 | $3.62M | 0.01% | +256,412 | New |
| Millennium Management LLC | 274,748 | $3.88M | 0.00% | +274,748 | New |
| Soros Capital Management LLC | 588,235 | $8.30M | 4.16% | +588,235 | New |
| Johnson & Johnson | 912,128 | $12.9M | 4.74% | +912,128 | New |
| OrbiMed Advisors LLC | 1,500,000 | $21.2M | 0.49% | +1,500,000 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,699,313 | $24.0M | 0.54% | +1,699,313 | New |
| Avidity Partners Management LP | 1,800,000 | $25.4M | 1.02% | +1,800,000 | New |
| EcoR1 Capital, LLC | 2,071,450 | $29.2M | 1.00% | +2,071,450 | New |
| Citadel Advisors LLC | 2,168,518 | $29.7M | 0.03% | +2,168,518 | New |
| Artal Group S.A. | 2,802,702 | $39.5M | 1.72% | +2,802,702 | New |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,124 | $46.7M | 0.62% | +3,309,124 | New |
| MIC Capital Management UK LLP | 4,460,700 | $62.9M | 14.35% | +4,460,700 | New |
| FMR LLC | 5,624,353 | $79.4M | 0.01% | +5,624,353 | New |
| Softbank Group Corp | 7,646,916 | $107.9M | 1.19% | +7,646,916 | New |